West Campus will house the Yale Cancer Biology Institute.  This center will bring together more than a dozen labs focusing on fundamental and translational cancer biology.  The Institute will interact with the Genome Analysis, RNAi and Small Molecule Cores in a very direct manner and will benefit immensely from the scientific environment of the cell biology, chemical biology, microbial diversity and systems biology institutes.

The Cancer Biology Institute is an example of an interdisciplinary activity that will bring a diversity of researchers together to address one of the world’s most pressing health problems.

 

Faculty Advisory Committee:

Joseph Schlessinger (Pharmacology) ,Chair
Daniel DiMaio (Genetics)

David Stern (Pathology)

Frank Slack (Molecular, Cellular, and Developmental Biology)

James Rothman (Cell Biology)

Karen Anderson (Pharmacology)

Mark Saltzman (Biomedical Engineering)

Nancy Carrasco (Physiology)
Peter Glazer (Genetics and Therapeutic Radiology,Chair)

Richard Lifton (Genetics)

Roy Herbst ( Pharmacology)

Scott Storbel (Molecular Biophysics and Biochemistry)

Susan Baserga ( Molecular Biophysics and Biochemistry, Genetics, and Therapeutic Radiology)

Thomas Lynch( Internal Medicine and Yale Cancer Center, Director)

William Jorgensen( Chemistry)

For more information about the Yale Cancer Biology Institute, please contact:

Dr. Joseph Schlessinger

Dr. Joseph Schlessinger, Director of the Yale Cancer Biology Institute and William H. Prusoff Professor and Chairman of Pharmacology joseph.schlessinger@yale.edu

203-785-7395